Royal jelly: a natural therapeutic?

Year 2019, , 333 - 341, 01.09.2019

Ali Korhan Sığ , Özlem Öz-sığ Mustafa Güney

https://doi.org/10.21601/ortadogutipdergisi.500434

Cited By: 1

Abstract

Royal jelly is a secretion of honeybees that is actually for feeding of bee larvae. It contains many bioactive substances such as jelleins, royalisin, major royal jelly proteins and 10-hydroxy-2-decenoic acid. Recently, many studies were published investigating activities of royal jelly. In overall, royal jelly found to have antioxidant, neurotrophic, antidiabetic, hypocholesterolemic, regulatory on blood pressure, antimicrobial, immunomodulatory, anti-tumor and tissue-protective effects. These activities are strongly related to each other and cannot be evaluated separately. Researchers claim that royal jelly can be an excellent therapeutic agent (or an additional agent), especially in treatments of cancer and metabolic syndrome. However, there are huge gaps due to limited number of in vivo studies and there are standardization issues both for usage and investigations. Furthermore, wide variability of contents in royal jelly due to geographic locations, climate, etc also causes a problem in choice of exact royal jelly. Currently it seems to be safe and effective nutritious agent for healthy people, but it is hard to gain an overall perspective in usage as a therapeutic, since there is a necessity of wider studies with more different types of royal jelly.

Keywords

royal jelly, apitherapy, honeybee products, biopharmaceuticals, complementary medicine, integrative medicine

Arı sütü: doğal bir terapötik mi?

Abstract

Arı sütü aslen arı larvalarının beslenmesi için bal arıları tarafından üretilen bir sekresyondur. Jelleinler, royalizin, ana arı sütü proteinleri ve 10-hidroksi-2-desenoik asit gibi çok sayıda biyoaktif madde içermektedir. Son yıllarda arı sütü konusunda çok sayıda makale yayımlanmıştır. Genel olarak, arı sütü, antioksidan, nörotropik, antidiyabetik, hipokolesterolemik, kan basıncı düzenleyici, antimikrobiyal, immünomodülatör, anti-tümör ve doku koruyucu etkileri göstermektedir. Bu etkiler aslen bir bütündür ve mekanizmaları ayrı ayrı değerlendirmek mümkün değildir. Araştırmacılar, özellikle kanser ve metabolik sendrom tedavisinde iyi bir tedavi ajanı (veya tedaviye ek bir ajan) olabileceğini iddia etmektedir. Öte yandan, in vivo çalışmaların sayısı son derece sınırlıdır ve hem araştırma hem kullanım alanlarında standardizasyon sorunu vardır. Ayrıca, coğrafi konum, iklim gibi koşullara bağlı olarak arı sütü içeriğinin ciddi farklılıklar göstermesi, arı sütünün seçiminde sorunlar yaratmaktadır. Şu an için, sağlıklı insanlarda güvenli ve etkin bir besleyici gıda olarak gözükmekte, fakat terapötik kullanımı konusunda genel bir görüş elde etmek mümkün gözükmemektedir. Farklı türlerde arı sütleri üzerinde daha geniş çaplı araştırmalar yapılmalıdır.

Keywords

arı sütü, apiterapi, arı ürünleri, biyofarmasötik ajanlar, geleneksel ve tamamlayıcı tıp

References

• Cherbuliez T. Apitherapy - The Use of Honeybee Products. In: Grassberger M, Sherman RA, Gileva OS, Kim CMH, Mumcuoglu KY (editors). Biotherapy - History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease using Living Organisms. London: Springer Science & Business Media; 2013: 113-46.
• Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev 2017. (doi: 10.1155/2017/1259510).
• Pavel CI, Mărghitaş LA, Bobiş O, Dezmirean DS, Şapcaliu A, Radoi I, Mădaş MN. Biological activities of royal jelly-review. Scientific Papers Animal Science and Biotechnologies 2011; 44: 108-18.
• Cornara L, Biagi M, Xiao J, Burlando B. Therapeutic properties of bioactive compounds from different honeybee products. Front Pharmacol 2017. (doi: 10.3389/fphar.2017.00412).
• Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, Pérez-Álvarez JA. Functional properties of honey, propolis, and royal jelly. J Food Sci 2008; 73: 117-24.
• Inoue SI, Koya-Miyata S, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Royal Jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage. Exp Gerontol 2003; 38: 965-9.
• Narita Y, Ohta S, Suzuki KM, Nemoto T, Abe K, Mishima S. Effects of long-term administration of royal jelly on pituitary weight and gene expression in middle-aged female rats. Biosci Biotechnol Biochem 2009; 73: 431-3.
• Rafat N, Monfared AS, Shahidi M, Pourfallah TA. The modulating effect of royal jelly consumption against radiation-induced apoptosis in human peripheral blood leukocytes. J Med Phys 2016; 41: 52-7.
• El-Nekeety AA, El-Kholy W, Abbas NF, Ebaid A, Amra HA, Abdel-Wahhab MA. Efficacy of royal jelly against the oxidative stress of fumonisin in rats. Toxicon 2007; 50: 256-69.
• Silici S, Ekmekcioglu O, Eraslan G, Demirtas A. Antioxidative effect of royal jelly in cisplatin-induced testes damage. Urology 2009; 74: 545-51.
• Anbara H, Shahrooz R, Malekinejad H, Saadati S. Protective Effects of Royal Jelly and Vitamin C against Experimental Hemolytic Anemia on Sex Hormones and Histochemical Testicle Tissue Histochemistry of Adult Mice. JSSU 2016; 23: 1140-54.
• Manas GE, Najafi G. Protective effects of royal jelly on the histomorphologic, oxidative stress and sperm parameters in Ofloxacin treated rat. Comp Clin Path 2017; 26: 1111-5.
• Ghanbari E, Khazaei MR, Khazaei M, Nejati V. Royal Jelly Promotes Ovarian Follicles Growth and Increases Steroid Hormones in Immature Rats. Int J Fertil Steril 2018; 11: 263–9.
• Abdel-Hafez SMN, Rifaai RA, Abdelzaher WY. Possible protective effect of royal jelly against cyclophosphamide induced prostatic damage in male albino rats; a biochemical, histological and immuno-histo-chemical study. Biomed Pharmacother 2017; 90: 15-23.
• Pajovic B, Radojevic N, Dimitrovski A, Tomovic S, Vukovic M. The therapeutic potential of royal jelly in benign prostatic hyperplasia. Comparison with contemporary literature. Aging Male 2016; 19: 192-6.
• Karadeniz A, Simsek N, Karakus E, et al. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid Med Cell Longev 2011. (doi: 10.1155/2011/981793).
• Yapar K, Cavusoglu K, Oruc E, Yalcin E. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study. J Med Food 2009; 12: 1136-42.
• Osama H, Abdullah A, Gamal B, Emad D, Sayed D, Hussein E, et al. Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer. J Am Coll Nutr 2017. (doi: 10.1080/07315724.2017.1292157).
• Ibrahim A, Eldaim MAA, Abdel-Daim MM. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats. Cytotechnology 2016; 68: 1039-48.
• Nejati V, Zahmatkesh E, Babaei M. Protective Effects of Royal Jelly on Oxymetholone-Induced Liver Injury in Mice. Iran Biomed J 2016; 20: 229-34.
• Malekinejad H, Ahsan S, Delkhosh-Kasmaie F, Cheraghi H, Rezaei-Golmisheh A, Janbaz-Acyabar H. Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats. Iran J Basic Med Sci 2016; 19: 221-7.
• Ghanbari E, Nejati V, Khazaei M. Improvement in serum biochemical alterations and oxidative stress of liver and pancreas following use of royal jelly in streptozotocin-induced diabetic rats. Cell Journal (Yakhteh) 2016; 18: 362.
• Kanbur M, Eraslan G, Beyaz L, Silici S, Liman BC, Altinordulu S, Atasever A. The effects of royal jelly on liver damage induced by paracetamol in mice. Exp Toxicol Pathol 2009; 61: 123-32.
• Kamakura M, Suenobu N, Fukushima M. Fifty-seven-kDa protein in royal jelly enhances proliferation of primary cultured rat hepatocytes and increases albumin production in the absence of serum. Biochem Biophys Res Commun 2001; 282: 865-74.
• Inoue S, Kawashima M, Hisamura R, et al. Clinical evaluation of a royal jelly supplementation for the restoration of dry eye: A prospective randomized double blind placebo controlled study and an experimental mouse model. PloS One 2017. (doi: 10.1371/journal.pone.0169069).
• Narita Y, Nomura J, Ohta S, et al. Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem 2006; 70: 2508-14.
• Hidaka S, Okamoto Y, Uchiyama S, et al. Royal jelly prevents osteoporosis in rats: beneficial effects in ovariectomy model and in bone tissue culture model. Evid Based Complement Alternat Med 2006. (doi: 10.1093/ecam/nel019).
• Pourmoradian S, Mahdavi R, Mobasseri M, Faramarzi E, Mobasseri M. Effects of royal jelly supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: A randomized clinical trial. Chin J Integr Med 2014; 20(5): 347-352.
• Makino J, Ogasawara R, Kamiya T, et al. Royal Jelly constituents increase the expression of extracellular superoxide dismutase through histone acetylation in monocytic THP-1 cells. J Nat Prod 2016; 79: 1137-43.
• Teixeira RR, de Souza AV, Peixoto LG, et al. Royal jelly decreases corticosterone levels and improves the brain antioxidant system in restraint and cold stressed rats. Neurosci Lett 2017; 655: 179-85.
• Juszczak L, Gałkowska D, Ostrowska M, Socha R. Antioxidant activity of honey supplemented with bee products. Nat Prod Res 2016; 30: 1436-9.
• Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S. Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro. Biomed Res 2007; 28: 261-6.
• Hattori N, Ohta S, Sakamoto T, Mishima S, Furukawa S. Royal jelly facilitates restoration of the cognitive ability in trimethyltin-intoxicated mice. Evid Based Complement Alternat Med 2011. (doi: 10.1093/ecam/nep029).
• Zamani Z, Reisi P, Alaei H, Pilehvarian AA. Effect of Royal Jelly on spatial learning and memory in rat model of streptozotocin-induced sporadic Alzheimer’s disease. Adv Biomed Res 2012. (doi: 10.4103/2277-9175.98150).
• Wang X, Cao M, Dong Y. Royal jelly promotes DAF-16-mediated proteostasis to tolerate β-amyloid toxicity in C.elegans model of Alzheimer’s disease. Oncotarget 2016; 7: 54183-93.
• Chen D, Liu F, Wan JB, Lai CQ, Shen LR. Effect of Major Royal Jelly Proteins on Spatial Memory in Aged Rats: Metabolomics Analysis in Urine. J Agric Food Chem 2017; 65: 3151-9.
• Hashimoto M, Kanda M, Ikeno K, et al. Oral administration of royal jelly facilitates mRNA expression of glial cell line-derived neurotrophic factor and neurofilament H in the hippocampus of the adult mouse brain. Biosci Biotechnol Biochem 2005; 69: 800-5.
• Morita H, Ikeda T, Kajita K, et al. Effect of royal jelly ingestion for six months on healthy volunteers. Nutr J 2012; 11: 77.
• Minami A, Matsushita H, Ieno D, Matsuda Y, Horii Y, Ishii A, et al. Improvement of neurological disorders in postmenopausal model rats by administration of royal jelly. Climacteric 2016; 19: 568-73.
• Zamami Y, Takatori S, Goda M, et al. Royal jelly ameliorates insulin resistance in fructose-drinking rats. Biol Pharm Bull 2008; 31: 2103-7.
• Ghanbari E, Nejati V, Khazaei M. Antioxidant and protective effects of Royal jelly on histopathological changes in testis of diabetic rats. Int J Reprod Biomed 2016; 14: 519-26.
• Münstedt K, Bargello M, Hauenschild A. Royal jelly reduces the serum glucose levels in healthy subjects. J Med Food 2009; 12: 1170-2.
• Yoshida M, Hayashi K, Watadani R, et al. Royal jelly improves hyperglycemia in obese/diabetic KK-Ay mice. J Vet Med Sci 2017; 79: 299-307.
• Khoshpey B, Djazayeri S, Amiri F, et al. Effect of royal jelly intake on serum glucose, apolipoprotein AI (ApoA-I), apolipoprotein B (ApoB) and ApoB/ApoA-I ratios in patients with type 2 diabetes: A randomized, double-blind clinical trial study. Can J Diabetes 2016; 40: 324-8.
• Guo H, Saiga A, Sato M, Miyazawa I, Shibata M, Takahata Y, Morimatsu F. Royal jelly supplementation improves lipoprotein metabolism in humans. J Nutr Sci Vitaminol 2007; 53: 345-8.
• Chiu HF, Chen BK, Lu YY, et al. Hypocholesterolemic efficacy of royal jelly in healthy mild hypercholesterolemic adults. Pharm Biol 2017; 55: 497-502.
• Lambrinoudaki I, Augoulea A, Rizos D, et al. Greek-origin royal jelly improves the lipid profile of postmenopausal women. Gynecol Endocrinol 2016; 32: 835-9.
• Münstedt K, Henschel M, Hauenschild A, von Georgi R. Royal jelly increases high density lipoprotein levels but in older patients only. J Altern Complem Med 2009; 15: 329-30.
• Hadi A, Najafgholizadeh A, Aydenlu ES, et al. Royal jelly is an effective and relatively safe alternative approach to blood lipid modulation: A meta-analysis. J Funct Foods 2018; 41: 202-9.
• Yoneshiro T, Kaede R, Nagaya K, et al. Royal jelly ameliorates diet-induced obesity and glucose intolerance by promoting brown adipose tissue thermogenesis in mice. Obes Res Clin Pract 2016. (doi: 10.1016/j.orcp.2016.12.006).
• Takaki-Doi S, Hashimoto K, Yamamura M, Kamei C. Antihypertensive activities of royal jelly protein hydrolysate and its fractions in spontaneously hypertensive rats. Acta Med Okayama 2009; 63: 57-64.
• Fan P, Han B, Feng M, et al. Functional and Proteomic Investigations Reveal Major Royal Jelly Protein 1 Associated with Anti-hypertension Activity in Mouse Vascular Smooth Muscle Cells. Sci Rep 2016; 6: 30230.
• Townsend GF, Morgan JF, Tolnai S, Hazlett B, Morton HJ, Shuel RW. Studies on the in vitro antitumor activity of fatty acids I: 10-hydroxy-2-decenoic acid from royal jelly. Cancer Res 1960; 20: 503-10.
• Shirzad M, Kordyazdi R, Shahinfard N, Nikokar M. Does Royal jelly affect tumor cells? J Herbmed Pharmacol 2013; 2: 45-8.
• Izuta H, Chikaraishi Y, Shimazawa M, Mishima S, Hara H. 10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells. Evid Based Complement Alternat Med 2009. (doi: 10.1093/ecam/nem152).
• Zhang S, Shao Q, Shen Z, Su S. Immunomodulatory response of 4T1 murine breast cancer model to camellia royal jelly. Biomed Res 2017; 28: 1223-30.
• Šver L, Oršolić N, Tadić Z, Njari B, Valpotic I, Bašic I. A royal jelly as a new potential immunomodulator in rats and mice. Comp Immunol Microbiol Infect Dis 1996; 19: 31-8.
• Kohno K, Okamoto I, Sano O, Arai N, Iwaki K, Ikeda M, Kurimoto M. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 2004; 68: 138-45.
• Vucevic D, Melliou E, Vasilijic S, Gasic S, Ivanovski P, Chinou I, Colic M. Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro. Int Immunopharmacol 2007; 7: 1211-20.
• De Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174(5): 1209-1220.
• Gasic S, Vucevic D, Vasilijic S, Antunovic M, Chinou I, Colic M. Evaluation of the immunomodulatory activities of royal jelly components in vitro. Immunopharmacol Immunotoxicol 2007. (doi: 10.1080/08923970701690977).
• Kwon HO, Lee M, Cho YH, Jun W, Lee J. Royal jelly supplementation ameliorated immune impairment via inhibition of oxidative stress in low micronutrient-induced immunodeficient mice. J Food Nutr Res 2017; 5: 74-9.
• Zargar HR, Hemmati AA, Ghafourian M, Arzi A, Rezaie A, Javad-Moosavi SA. Long-term treatment with royal jelly improves bleomycin-induced pulmonary fibrosis in rats. Can J Physiol Pharmacol 2016; 95: 23-31.
• Mannoor MK, Shimabukuro I, Tsukamotoa M, Watanabe H, Yamaguchi K, Sato Y. Honeybee royal jelly inhibits autoimmunity in SLE-prone NZB× NZW F1 mice. Lupus 2009; 18(1): 44-52.
• Zahran AM, Elsayh KI, Saad K, et al. Effects of royal jelly supplementation on regulatory T cells in children with SLE. Food Nutr Res 2016; 60: 32963.
• Erem C, Deger O, Ovali E, Barlak Y. The effects of royal jelly on autoimmunity in Graves’ disease. Endocrine 2006; 30: 175-83.
• Fratini F, Cilia G, Mancini S, Felicioli A. Royal Jelly: An ancient remedy with remarkable antibacterial properties. Microbiol Res 2016; 192: 130-41.
• Alreshoodi FM, Sultanbawa Y. Antimicrobial Activity of Royal Jelly. Antiinfect Agents 2015; 13: 50-9.
• Brudzynski K, Sjaarda C. Honey Glycoproteins Containing Antimicrobial Peptides, Jelleins of the Major Royal Jelly Protein 1, Are Responsible for the Cell Wall Lytic and Bactericidal Activities of Honey. PLoS One 2015. (doi: 10.1371/journal.pone.0120238).
• Meto A, Meto A, Xhajanka E, Ozcan M, Tragaj E. Microbiological Comparison of Royal Jelly and Chlorhexidine 0.2%. European Journal of Interdisciplinary Studies 2017; 7: 122-5.
• Dinkov D, Stratev D, Balkanska R, Sergelidis D, Vashin I. Reduction Effect of Royal Jelly and Rape Honey Alone and in Combination Against Methicillin-Resistant Staphylococcus aureus (MRSA) Strains. J Bacteriol Virol 2016; 46: 36-43.
• Stratev D, Vashin I, Balkanska R, Dinkov D. Antibacterial activity of Royal jelly and rape honey against Aeromonas hydrophila (ATCC 7965). J Food Health Sci 2015; 1: 67-74.
• Mierzejewski M. The antimicrobial effects of royal jelly, propolis and honey against bacteria of clinical significance in comparison to three antibiotics. Available at: https://www.newhaven.edu/_resources/documents/academics/surf/past-projects/2013/monica-mierzejewski-paper.pdf (Accessed on: 1 Feb 2018)
• Susilowati H, Murakami K, Yumoto H, et al. Royal Jelly Inhibits Pseudomonas aeruginosa Adherence and Reduces Excessive Inflammatory Responses in Human Epithelial Cells. Biomed Res Int 2017. (doi: 10.1155/2017/3191752).
• Moghim H, Taghipoor S, Shahinfard N, Kheiri S, Khabbazi H. Comparative study on the antifungal activity of hydroalcoholic extract of Iranian Propolis and Royal jelly against Rhizopus oryzae. J Herbmed Pharmacol 2015; 4: 89-92.
• Siavash M, Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z. The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double‐blind placebo‐controlled clinical trial. Int Wound J 2015; 12: 137-42.
• Thien FCK, Leung R, Baldo BA, Weinbr J, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clin Exp Allergy 1996; 26: 216-22.